MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkemeyer, M. F.
Right arrow Articles by Charness, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkemeyer, M. F.
Right arrow Articles by Charness, M. E.

Vol. 62, Issue 5, 1053-1060, November 2002

Novel Antagonists of Alcohol Inhibition of L1-Mediated Cell Adhesion: Multiple Mechanisms of Action

Michael F. Wilkemeyer, Carrie E. Menkari, and Michael E. Charness

Neurology Service, VA Boston Healthcare System, West Roxbury, Massachusetts; Department of Neurology, Harvard Medical School, Boston, Massachusetts; and Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts

1-Octanol antagonizes ethanol inhibition of L1-mediated cell adhesion and prevents ethanol teratogenesis in mouse whole embryo culture. Herein, we identify a new series of alcohol antagonists and study their mechanism of action. Cell aggregation assays were carried out in ethanol-sensitive, human L1-transfected NIH/3T3 cells in the absence and presence of 100 mM ethanol or 2 mM 1-butanol and candidate antagonists. Antagonist potency for 1-alcohols increased progressively over 5 log orders from 1-pentanol (C5) to 1-dodecanol (C12). Antagonist potency declined from 1-dodecanol (C12) to 1-tridecanol (C13), and 1-tetradecanol (C14) and 1-pentadecanol (C15) were inactive. The presence and position of a double bond in the 1-butanol molecule determined whether a compound was a full agonist (1-butanol), a mixed agonist-antagonist (2-buten-1-ol), or an antagonist (3-buten-1-ol). Increasing the concentration of agonist (1-butanol or ethanol) overcame the antagonism of 3-buten-1-ol, benzyl alcohol, cyclopentanol, and 3-pentanol, but not that of 4-methyl-1-pentanol, 2-methyl-2-pentanol, 1-pentanol, 2-pentanol, 1-octanol, and 2,6-di-isopropylphenol (propofol), suggesting that the mechanisms of antagonism may differ between these groups of compounds. These findings suggest that selective straight, branched, and cyclic alcohols may act at multiple, discrete sites to antagonize the actions of ethanol and 1-butanol on L1-mediated cell-cell adhesion.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Alcohol AlcoholHome page
C. Guerri, A. Bazinet, and E. P. Riley
Foetal Alcohol Spectrum Disorders and Alterations in Brain and Behaviour
Alcohol Alcohol., March 1, 2009; 44(2): 108 - 114.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Arevalo, S. Shanmugasundararaj, M. F. Wilkemeyer, X. Dou, S. Chen, M. E. Charness, and K. W. Miller
An alcohol binding site on the neural cell adhesion molecule L1
PNAS, January 8, 2008; 105(1): 371 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
C. R. Goodlett, K. H. Horn, and F. C. Zhou
Alcohol Teratogenesis: Mechanisms of Damage and Strategies for Intervention
Experimental Biology and Medicine, June 1, 2005; 230(6): 394 - 406.
[Abstract] [Full Text] [PDF]

Home page
 Cereb CortexHome page
J. A. Siegenthaler and M. W. Miller
Transforming Growth Factor {beta}1 Modulates Cell Migration in Rat Cortex: Effects of Ethanol
Cereb Cortex, July 1, 2004; 14(7): 791 - 802.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. F. Wilkemeyer, S.-y. Chen, C. E. Menkari, K. K. Sulik, and M. E. Charness
Ethanol Antagonist Peptides: Structural Specificity without Stereospecificity
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1183 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. A. Greenberg
Linking acquired neurodevelopmental disorders to defects in cell adhesion
PNAS, July 8, 2003; 100(14): 8043 - 8044.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. F. Wilkemeyer, S.-y. Chen, C. E. Menkari, D. E. Brenneman, K. K. Sulik, and M. E. Charness
Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity
PNAS, July 8, 2003; 100(14): 8543 - 8548.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics